Cryo-Cell International Inc
CCEL4.974USD
+0.014+0.28%
시장 운영 시간 （ET）시세는 15분 지연됩니다
40.11M시가총액
311.65P/E TTM
자세한 내용은 Cryo-Cell International Inc 회사
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
회사 정보
종목 코드 CCEL
회사 이름Cryo-Cell International Inc
상장일Apr 04, 1994
CEOMr. Mark L. Portnoy
직원 수82
유형Ordinary Share
회계 연도 종료Apr 04
주소700 Brooker Creek Blvd
도시OLDSMAR
증권 거래소NYSE American Consolidated
국가United States of America
우편 번호34677
전화18137492104
웹사이트https://www.cryo-cell.com/
종목 코드 CCEL
상장일Apr 04, 1994
CEOMr. Mark L. Portnoy
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.57M
--
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
+14.88%
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Dr. Joanne Kurtzberg, M.D.
Dr. Joanne Kurtzberg, M.D.
Medical Director
Medical Director
--
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.57M
--
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
+14.88%
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Dr. Joanne Kurtzberg, M.D.
Dr. Joanne Kurtzberg, M.D.
Medical Director
Medical Director
--
--
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Processing and storage fees
7.87M
98.71%
Public banking revenue
82.08K
1.03%
Product revenue
20.91K
0.26%
데이터 없음
사업별
지역별
사업별USD
이름
수익
비율
Processing and storage fees
7.87M
98.71%
Public banking revenue
82.08K
1.03%
Product revenue
20.91K
0.26%
주식 보유 통계
마지막 업데이트: Sat, May 17
마지막 업데이트: Sat, May 17
주주
주주 유형
주주
주주
비율
Portnoy (David I)
19.50%
Portnoy (Mark)
11.61%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
55.43%
주주
주주
비율
Portnoy (David I)
19.50%
Portnoy (Mark)
11.61%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
55.43%
주주 유형
주주
비율
Individual Investor
40.39%
Investment Advisor
6.26%
Private Equity
5.09%
Hedge Fund
0.80%
Investment Advisor/Hedge Fund
0.64%
Other
46.83%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
38
4.28M
53.09%
-1.50K
2025Q1
39
4.88M
60.37%
-1.40K
2024Q4
36
4.88M
60.35%
-45.33K
2024Q3
31
4.73M
58.53%
-190.45K
2024Q2
32
4.72M
57.24%
-175.49K
2024Q1
34
4.70M
56.72%
-231.88K
2023Q4
36
4.69M
56.61%
-257.13K
2023Q3
34
4.69M
56.58%
-265.51K
2023Q2
34
4.80M
57.00%
-223.23K
2023Q1
36
5.70M
67.38%
-813.20K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Portnoy (David I)
1.57M
19.44%
--
--
Feb 28, 2025
Portnoy (Mark)
935.77K
11.58%
--
--
Feb 28, 2025
Fleishman (Adam)
509.00K
6.3%
--
--
Feb 28, 2025
Hamilton Lane Advisors, LLC
409.73K
5.07%
--
--
Jun 30, 2025
SFI Advisors LLC
165.30K
2.05%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
118.23K
1.46%
+1.28K
+1.09%
Mar 31, 2025
The MassMutual Trust Company, FSB
111.03K
1.37%
--
--
Mar 31, 2025
Mikulinsky (Oleg)
104.35K
1.29%
--
--
Feb 28, 2025
Berger (Harold D)
50.40K
0.62%
--
--
Feb 28, 2025
Topline Capital Management, LLC
47.79K
0.59%
--
--
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
비율0.01%
주식 배당금
지난 5년 동안 총
9.69M
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Jan 29, 2025
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Feb 28, 2025
Feb 14, 2025
Oct 31, 2024
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
